Medacta Group Sa Stock Net Income
| MOVE Stock | 150.20 1.60 1.08% |
As of the 18th of February 2026, Medacta Group secures the Mean Deviation of 1.13, downside deviation of 1.71, and Risk Adjusted Performance of 0.0265. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medacta Group SA, as well as the relationship between them. Please verify Medacta Group SA coefficient of variation, variance, and the relationship between the downside deviation and standard deviation to decide if Medacta Group SA is priced some-what accurately, providing market reflects its recent price of 150.2 per share.
Medacta Group Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 5.0113 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 83.8 M | 47.1 M | |
| Net Income Applicable To Common Shares | 83.8 M | 47.1 M | |
| Net Income | 83.8 M | 47.1 M | |
| Net Income Per Share | 3.28 | 1.71 | |
| Net Income Per E B T | 0.75 | 0.66 |
Medacta | Net Income |
The evolution of Net Income for Medacta Group SA provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Medacta Group compares to historical norms and industry peers.
Latest Medacta Group's Net Income Growth Pattern
Below is the plot of the Net Income of Medacta Group SA over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Medacta Group SA financial statement analysis. It represents the amount of money remaining after all of Medacta Group SA operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Medacta Group's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medacta Group's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 72.89 M | 10 Years Trend |
|
Net Income |
| Timeline |
Medacta Net Income Regression Statistics
| Arithmetic Mean | 44,216,338 | |
| Geometric Mean | 41,432,559 | |
| Coefficient Of Variation | 35.11 | |
| Mean Deviation | 10,021,692 | |
| Median | 39,219,000 | |
| Standard Deviation | 15,524,039 | |
| Sample Variance | 241T | |
| Range | 72M | |
| R-Value | 0.52 | |
| Mean Square Error | 186.5T | |
| R-Squared | 0.27 | |
| Significance | 0.03 | |
| Slope | 1,610,706 | |
| Total Sum of Squares | 3855.9T |
Medacta Net Income History
Medacta Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Medacta Group is extremely important. It helps to project a fair market value of Medacta Stock properly, considering its historical fundamentals such as Net Income. Since Medacta Group's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Medacta Group's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Medacta Group's interrelated accounts and indicators.
Click cells to compare fundamentals
Medacta Group 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medacta Group's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medacta Group.
| 11/20/2025 |
| 02/18/2026 |
If you would invest 0.00 in Medacta Group on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding Medacta Group SA or generate 0.0% return on investment in Medacta Group over 90 days. Medacta Group is related to or competes with Tecan Group, BB Biotech, Galenica Sante, Ypsomed Holding, Medartis Holding, SKAN Group, and Aevis Victoria. Medacta Group is entity of Switzerland. It is traded as Stock on SW exchange. More
Medacta Group Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medacta Group's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medacta Group SA upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.71 | |||
| Information Ratio | (0) | |||
| Maximum Drawdown | 10.81 | |||
| Value At Risk | (2.59) | |||
| Potential Upside | 2.83 |
Medacta Group Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medacta Group's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medacta Group's standard deviation. In reality, there are many statistical measures that can use Medacta Group historical prices to predict the future Medacta Group's volatility.| Risk Adjusted Performance | 0.0265 | |||
| Jensen Alpha | 0.0317 | |||
| Total Risk Alpha | (0.04) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | 0.5194 |
Medacta Group February 18, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0265 | |||
| Market Risk Adjusted Performance | 0.5294 | |||
| Mean Deviation | 1.13 | |||
| Semi Deviation | 1.62 | |||
| Downside Deviation | 1.71 | |||
| Coefficient Of Variation | 3704.5 | |||
| Standard Deviation | 1.63 | |||
| Variance | 2.67 | |||
| Information Ratio | (0) | |||
| Jensen Alpha | 0.0317 | |||
| Total Risk Alpha | (0.04) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | 0.5194 | |||
| Maximum Drawdown | 10.81 | |||
| Value At Risk | (2.59) | |||
| Potential Upside | 2.83 | |||
| Downside Variance | 2.92 | |||
| Semi Variance | 2.61 | |||
| Expected Short fall | (1.21) | |||
| Skewness | (0.27) | |||
| Kurtosis | 3.0 |
Medacta Group SA Backtested Returns
Medacta Group SA has Sharpe Ratio of close to zero, which conveys that the firm had a close to zero % return per unit of risk over the last 3 months. Medacta Group exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Medacta Group's Mean Deviation of 1.13, downside deviation of 1.71, and Risk Adjusted Performance of 0.0265 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.0656, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Medacta Group's returns are expected to increase less than the market. However, during the bear market, the loss of holding Medacta Group is expected to be smaller as well. At this point, Medacta Group SA has a negative expected return of -0.0027%. Please make sure to verify Medacta Group's semi deviation, coefficient of variation, jensen alpha, as well as the relationship between the downside deviation and standard deviation , to decide if Medacta Group SA performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.47 |
Modest reverse predictability
Medacta Group SA has modest reverse predictability. Overlapping area represents the amount of predictability between Medacta Group time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medacta Group SA price movement. The serial correlation of -0.47 indicates that about 47.0% of current Medacta Group price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.47 | |
| Spearman Rank Test | -0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 41.96 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Medacta Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Medacta Group SA reported net income of 72.89 M. This is 78.64% lower than that of the Health Care Equipment & Supplies sector and 69.39% lower than that of the Health Care industry. The net income for all Switzerland stocks is 87.23% higher than that of the company.
Medacta Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medacta Group's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medacta Group could also be used in its relative valuation, which is a method of valuing Medacta Group by comparing valuation metrics of similar companies.Medacta Group is currently under evaluation in net income category among its peers.
Medacta Group Current Valuation Drivers
We derive many important indicators used in calculating different scores of Medacta Group from analyzing Medacta Group's financial statements. These drivers represent accounts that assess Medacta Group's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Medacta Group's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 2.7B | 2.1B | 2.7B | 2.3B | 2.0B | 1.7B | |
| Enterprise Value | 2.8B | 2.2B | 2.9B | 2.5B | 2.2B | 1.9B |
Medacta Fundamentals
| Return On Equity | 0.25 | ||||
| Return On Asset | 0.0848 | ||||
| Profit Margin | 0.15 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 2.96 B | ||||
| Shares Outstanding | 19.94 M | ||||
| Shares Owned By Insiders | 69.64 % | ||||
| Shares Owned By Institutions | 18.42 % | ||||
| Price To Book | 7.60 X | ||||
| Price To Sales | 4.59 X | ||||
| Revenue | 590.58 M | ||||
| Gross Profit | 436.82 M | ||||
| EBITDA | 160.51 M | ||||
| Net Income | 72.89 M | ||||
| Total Debt | 241.21 M | ||||
| Book Value Per Share | 19.42 X | ||||
| Cash Flow From Operations | 107.14 M | ||||
| Earnings Per Share | 4.35 X | ||||
| Target Price | 178.13 | ||||
| Number Of Employees | 2.04 K | ||||
| Beta | 1.18 | ||||
| Market Capitalization | 2.96 B | ||||
| Total Asset | 792.18 M | ||||
| Retained Earnings | 346.07 M | ||||
| Working Capital | 237.83 M | ||||
| Annual Yield | 0 % | ||||
| Net Asset | 792.18 M | ||||
| Last Dividend Paid | 0.74 |
About Medacta Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medacta Group SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medacta Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medacta Group SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Medacta Stock Analysis
When running Medacta Group's price analysis, check to measure Medacta Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medacta Group is operating at the current time. Most of Medacta Group's value examination focuses on studying past and present price action to predict the probability of Medacta Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medacta Group's price. Additionally, you may evaluate how the addition of Medacta Group to your portfolios can decrease your overall portfolio volatility.